Asia-Pacific Journal of Oncology (AJO, Asia Pac J Oncol, p-ISSN: 2708-7980, e-ISSN: 2708-7999) is an open access, international, peer-reviewed journal, published by Asian Medical Press in London, UK. It is published biannually and is openly distributed worldwide. AJO publishes the results of novel research in the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human oncology with the overall goal of improving the clinical care of patients with tumor. It covers some main human tumor types: cerebral tumor, head and neck neoplasm, thoracic neoplasms, breast caner, gastrointestinal cancer, urologic oncology, bone tumour and other any neoplasms types in human.
Editorial board
Editors-in-Chief: Katarzyna Rygiel (Department of Family Practice, Medical University of Silesia, Zabrze, Poland); Ning Li (Chief of Physician of Thoracic Surgery, National Cancer Center, Cancer Hospital Chinese Academy of Medical Sciences, China). More >>
Indexing Google Scholar, ResearchGate
Current Issue Volume 4, 2023 >>
Neuroendocrine breast carcinoma (NEBC), an infrequent malignancy, accounts for 2–5% of all invasive breast cancer cases. The minimal occurrence of the ...
Mohsen S. Ali
REVIEW | 27 Nov 2024
Despite recent improvements in diagnosis and treatment, breast cancer (BC) remains one of the leading causes of cancer-related deaths among women. In ...
Muhammad Waseem Akram, Bai Chen
REVIEW | 08 Nov 2024
MicroRNAs (miRNAs), a class of non-coding RNAs, play a critical role in regulating gene expression and have demonstrated significant potential as biom ...
Yifan Ou, Zhen Ren
REVIEW | 22 Oct 2024
This review explores recent advances in tumor diagnosis and early detection, focusing on cutting-edge developments in molecular diagnostic technologie ...
Rodney Bradly
REVIEW | 08 Oct 2024
Glioma-related cognitive dysfunction has emerged as a significant issue that affects the quality of life of patients. This paper aims to review the la ...
Riffat Iqbal, Zeeshan Ashraf
REVIEW | 11 Sep 2024
Non-small cell lung cancer (NSCLC) ranks among the top contributors to cancer-related mortality globally. Recently, immunotherapy, particularly immune ...
Palwasha Habib
REVIEW | 11 Sep 2024